Home >
Medicine Info >
Idrofos 150 mg Tablet
Loading interface...

Idrofos 150 mg Tablet

Manufactured bySun Pharma Laboratories Ltd.
ContainsIbandronate
Description
Idrofos 150 mg Tablet is used for the prevention and treatment of osteoporosis (a condition with weak and brittle bones). It works by preventing the breakdown of your bones and increasing bone density. This prevents your bones from getting weaker and reduces your risk of fractures. Idrofos 150 mg Tablet may cause common side effects such as stomach pain, indigestion, low blood calcium levels, tiredness, etc. Consult your doctor if these symptoms persist or worsen. Idrofos 150 mg Tablet should be taken exactly as directed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. It is recommended to take this medicine on an empty stomach, at least 30 minutes before having food. Do not lie down for 30 to 60 minutes after taking this medicine. Idrofos 150 mg Tablet should be avoided if you are allergic to it. Inform your doctor if you have pre-existing kidney, stomach/intestinal problems or a history of asthma before beginning treatment with this medicine. Idrofos 150 mg Tablet is not recommended for use in children below 18 years of age. If you are pregnant or breastfeeding or are planning a pregnancy, consult your doctor before taking this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Idrofos 150 mg Tablet

Bonrise 150 mg Tablet
Torrent Pharmaceuticals Ltd.
Flurish 150 mg Tablet
Dr. Reddys Laboratories Ltd.
Monthiba 150 mg Tablet
Panacea Biotec Ltd.
Vebalone 150 mg Tablet
Ranbaxy Laboratories Ltd.
Idrofos Kit
Sun Pharma Laboratories Ltd.

Side effects

Major & minor side effects for Idrofos 150 mg Tablet

  • Tiredness
  • Stomach pain
  • Indigestion
  • Decreased blood calcium levels
  • Chest pain
  • Itching or tingling sensation
  • Flu like symptoms
  • Dry mouth
  • Difficulty in swallowing
  • Increased urea levels in blood

Uses of Idrofos 150 mg Tablet

What is it prescribed for?

  • Osteoporosis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Idrofos 150 mg Tablet to show its effect is one to two hours of intake.
  • How long do the effects of this medicine last?
    The duration for which Idrofos 150 mg Tablet remains effective is not clinically known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Idrofos 150 mg Tablet.
  • Can this medicine be taken during pregnancy?
    Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus due to Idrofos 150 mg Tablet is not known. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Idrofos 150 mg Tablet passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.

Allergy

Avoid Idrofos 150 mg Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.

Hypocalcaemia

Idrofos 150 mg Tablet may cause hypocalcaemia (low blood calcium levels) and is not recommended for use if you have low blood calcium levels due to the increased risk of a severe decrease in your blood calcium levels.

Gastrointestinal disease

Idrofos 150 mg Tablet is not recommended if you have abnormalities of the oesophagus (food pipe) such as stricture or achalasia (conditions that delay oesophageal emptying) or if you have any conditions that affect your ability to stand or sit upright for at least 60 minutes due to the increased risk of worsening your condition.
Warnings for special population

Pregnancy

Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus due to Idrofos 150 mg Tablet is not known. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.

Breast-feeding

It is not known whether Idrofos 150 mg Tablet passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.
General warnings

Use in children

Idrofos 150 mg Tablet is not recommended for use in children below 18 years of age due to a lack of safety and efficacy studies.

Problems with bone and mineral metabolism

Hypocalcaemia (low blood calcium levels) and other problems of bone and mineral metabolism should be effectively treated before starting treatment with Idrofos 150 mg Tablet. Calcium and Vitamin D supplementation may be required based on your clinical condition.

Osteonecrosis of the jaw

Idrofos 150 mg Tablet may increase your risk of osteonecrosis of the jaw, a condition in which oral lesions occur in your jawbones. This risk is especially higher if you have poor oral hygiene, a history of dental problems or are undergoing any invasive dental procedures (tooth extractions), etc. It is recommended to maintain good oral hygiene, undergo routine dental check-ups, and immediately report any oral symptoms such as dental pain or swelling, during treatment with Idrofos 150 mg Tablet. Invasive dental procedures should be performed only after careful consideration.

Osteonecrosis of the external auditory canal

Idrofos 150 mg Tablet may increase your risk of osteonecrosis of the external auditory canal, a condition in which lesions occur in the tympanic bone of your ear. This risk is especially higher if you are on long-term treatment with Idrofos 150 mg Tablet, or are receiving chemotherapy for cancer or have chronic ear infections.

Other medicines

Idrofos 150 mg Tablet may interact with other medicines and cause undesired side effects. Hence, inform your doctor about your current medicines including any herbs and supplements before beginning treatment with this medicine.

Missed Dose

Try not to skip a dose of Idrofos 150 mg Tablet. Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Do not take more than the prescribed dose. Contact your doctor if you suspect an overdose with Idrofos 150 mg Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Aminoglycoside antibiotics

NSAIDs

Deferasirox

Sirolimus

Tenofovir

Tacrolimus

Cyclosporine

Disease interactions

Gastrointestinal Diseases

Idrofos 150 mg Tablet may increase your risk of stomach/intestinal problems such as ulceration and bleeding and hence this medicine should be used with caution if you have a history of stomach/intestinal problems. Inform your doctor if you experience any symptoms of severe abdominal pain, bloating, sudden dizziness/lightheadedness, nausea, vomiting, loss of appetite, black, tarry stools, etc. while on treatment with this medicine.

Kidney Disease

Idrofos 150 mg Tablet is eliminated by kidneys and should be used with caution if you have pre-existing kidney problems due to the increased risk of side effects, resulting from the accumulation of this medicine in your body. Your kidney function needs to be closely monitored and dose adjustments may be required based on your clinical condition.

Asthma

Idrofos 150 mg Tablet may increase your risk of asthma (a condition in which the air passages in your lungs become narrow and swollen, resulting in breathing difficulties). This risk is especially higher if you have a history of asthma. Inform your doctor if you experience breathing difficulties while on treatment with this medicine. You may require dose adjustments based on your clinical condition.
Food interactions
Food may reduce the absorption and effectiveness of Idrofos 150 mg Tablet. It is recommended to take this medicine on an empty stomach, at least 30 before having food.
Multivitamins with minerals may reduce the absorption and effectiveness of Idrofos 150 mg Tablet when taken together. It is recommended to maintain a time gap of at least 30 minutes between the administration of these medicines.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Idrofos 150 mg Tablet on an empty stomach for better absorption. Do not take more or less than the prescribed dose. Do not stop the use of this medicine without consulting your doctor. Take Idrofos 150 mg Tablet with a glass of plain water while you are standing or sitting in an upright position. Do not lie down for 30 to 60 minutes after taking this medicine. Take Idrofos 150 mg Tablet as a whole. Do not chew, suck, or crush this tablet as it may cause oropharyngeal ulceration (sores in your mouth or throat). Idrofos 150 mg Tablet may cause hypocalcaemia (low blood calcium levels). Your blood calcium levels need to be closely monitored. Multivitamins with mineral supplements may reduce the absorption and effectiveness of Idrofos 150 mg Tablet when taken together. Hence maintain a time gap of at least 30 minutes between the administration of these medicines. Maintain good oral hygiene, undergo routine dental check-ups, and report any symptoms of dental pain or swelling that you may experience during treatment with Idrofos 150 mg Tablet to your doctor immediately.
Miscelleneous

To be taken on an empty stomach

To be taken in morning only

Does not cause sleepiness

How it works
Idrofos 150 mg Tablet works by reducing the amount of calcium lost from your bones. This prevents your bones from getting weaker and reduces your risk of bone breakage (fractures).
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Bisphosphonates

Schedule

Schedule H

Medicines.org.uk. 2021. Ibandronic Acid 50mg Film-coated Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 16 December 2021].

https://www.medicines.org.uk/emc/product/4642/smpc>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 16 December 2021].

https://www.medicines.org.uk/emc/files/pil.4642.pdf>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 16 December 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf>

Rad-ar.or.jp. 2021. Search results detail| Kusurino-Shiori(Drug information Sheet). [online] Available at: < [Accessed 16 December 2021].

https://www.rad-ar.or.jp/siori/english/kekka.cgi?n=41755>

Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: < [Accessed 16 December 2021].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-02474-1&d=20211216172310101>

Drugs, H., 2021. Ibandronate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 16 December 2021].

https://medlineplus.gov/druginfo/meds/a605035.html>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 29 Dec 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.